Go Pro
→ AI billionaires are selling. Quickly. (From The Oxford Club) (Ad)tc pixel Free HLN Stock Alerts

Haleon (HLN) Stock Forecast & Price Target

Haleon logo
GBX 363.50 +1.90 (+0.53%)
As of 07/24/2026 12:05 PM Eastern
Compare

Haleon - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Hold
Based on 6 Analyst Ratings
Sell
2
Hold
1
Buy
3

Based on 6 Wall Street analysts who have issued ratings for Haleon in the last 12 months, the stock has a consensus rating of "Hold." Out of the 6 analysts, 2 have given a sell rating, 1 has given a hold rating, and 3 have given a buy rating for HLN.

Consensus Price Target

GBX 393.67
According to the 6 analysts' twelve-month price targets for Haleon, the average price target is GBX 393.67. The highest price target for HLN is GBX 512, while the lowest price target for HLN is GBX 315. The average price target represents a forecasted upside of 8.30% from the current price of GBX 363.50.
MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
Get the Latest News and Ratings for HLN and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Haleon and its competitors.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HLN Analyst Ratings Over Time

TypeCurrent Forecast
7/26/25 to 7/26/26		1 Month Ago
6/26/25 to 6/26/26		3 Months Ago
4/27/25 to 4/27/26		1 Year Ago
7/26/24 to 7/26/25
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
3 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
1 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
Consensus Price TargetGBX 393.67GBX 395.33GBX 407GBX 457
Consensus RatingHoldModerate BuyModerate BuyBuy

HLN Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HLN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Haleon Stock vs. The Competition

TypeHaleonMedical Companies
Consensus Rating Score
2.17
2.29
Consensus RatingHoldHold
News Sentiment Rating
Neutral News

See Recent HLN News
Positive News
Export
DateBrokerageAnalystActionRatingPrice TargetReport Date
Upside/Downside		Details
7/1/2026
Deutsche Bank Aktiengesellschaft logo
Deutsche Bank Aktiengesellschaft
2 of 5 stars
 Reiterated RatingSellGBX 325-7.35%
6/25/2026
JPMorgan Chase & Co. logo
JPMorgan Chase & Co.
3 of 5 stars
 Lower TargetUnderweightGBX 335 ➝ GBX 315-9.51%
5/5/2026
Jefferies Financial Group Inc. logo
Jefferies Financial Group
2 of 5 stars
 Lower TargetBuyGBX 450 ➝ GBX 400+19.12%
4/30/2026
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingSector performGBX 370 ➝ GBX 370+8.63%
4/30/2026
Berenberg Bank logo
Berenberg Bank
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingBuyGBX 512 ➝ GBX 512+49.86%
9/10/2025
The Goldman Sachs Group, Inc. logo
The Goldman Sachs Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
 Reiterated RatingNeutral ➝ BuyGBX 440+18.44%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 09:45 AM ET.


Should I Buy Haleon Stock? HLN Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, July 21, 2026. Please send any questions or comments about these Haleon pros and cons to contact@marketbeat.com.

Haleon
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Haleon plc:

  • Haleon plc has a diverse product portfolio that includes well-known brands like Advil, Centrum, and Sensodyne, which are built on trusted science and innovation, potentially leading to strong consumer loyalty and sales stability.
  • The company has recently been recognized for its commitment to delivering better everyday health, which aligns with growing consumer trends towards health and wellness, potentially increasing market demand for its products.
  • The current stock price is around $15, reflecting a stable position in the market, which may attract investors looking for reliable investment opportunities in the consumer health sector.
  • As an independent company listed on both the London and New York Stock Exchanges, Haleon plc offers investors access to international markets, enhancing liquidity and investment options.
  • Recent innovations in product formulations and marketing strategies may position Haleon plc favorably against competitors, potentially leading to increased market share and profitability.

Haleon
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Haleon plc for these reasons:

  • Despite its strong brand portfolio, Haleon plc operates in a highly competitive market, which could pressure profit margins and limit growth potential.
  • Market volatility and economic uncertainties can impact consumer spending on health products, which may adversely affect Haleon plc's sales performance.
  • As a relatively new independent entity, Haleon plc may face challenges in establishing its identity and market position compared to established competitors.
  • Investors may be concerned about the company's ability to sustain growth in a market that is increasingly focused on digital health solutions, which may require significant investment in technology and innovation.
  • Recent fluctuations in stock performance could indicate underlying market concerns, making some investors wary of potential risks associated with investing in Haleon plc.

HLN Forecast - Frequently Asked Questions

According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for Haleon is GBX 393.67, with a high forecast of GBX 512 and a low forecast of GBX 315.

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Haleon in the last year. There are currently 2 sell ratings, 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" HLN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HLN, but not buy additional shares or sell existing shares.

According to analysts, Haleon's stock has a predicted upside of 8.30% based on their 12-month stock forecasts.

Haleon has been rated by research analysts at Berenberg Bank, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., and Royal Bank Of Canada in the past 90 days.

Analysts like Haleon less than other "medical" companies. The consensus rating score for Haleon is 2.17 while the average consensus rating score for "medical" companies is 2.29. Learn more on how HLN compares to other companies.

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Haleon Recommendations


This page (LON:HLN) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners
The comeback story of the century (ticker inside)
In 2013, this struggling PC maker went private amid skepticism from Forbes and the New York Times. Instead of ...
InvestorPlace | Sponsoredtc pixel
Universal basic income is not impossible. It exist (kind of)
Robert Kiyosaki, author of Rich Dad Poor Dad, is highlighting an income strategy he calls the Patriot Income P...
Freedom Financial | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
This tiny piece of glass could be bigger than GPUs
Jensen Huang says AI can't scale without it. Google Ventures calls it the future of AI compute. Sequoia Capita...
Brownstone Research | Sponsoredtc pixel
Oxford Club Analyst’s Urgent AI Warning
Alexander Green, Chief Investment Strategist at The Oxford Club, is sharing a private presentation with a warn...
The Oxford Club | Sponsoredtc pixel
The 90%-off options that empty accounts
A call that cost $3.00 last month now trades for $0.30 - a 90% discount that looks tempting. It's not a bar...
Profits Run | Sponsoredtc pixel
Have you seen Elon’s new “supercurrency”? (It affects you)
Elon Musk just became the world's first trillionaire following the biggest IPO in history, giving him access t...
StocksToTrade | Sponsoredtc pixel